Welcome to the Heneka Lab!

Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease.
Chalermpalanupap T, Kinkead B, Hu WT, Kummer MP, Hammerschmidt T, Heneka MT, Weinshenker D, Levey AI.
Alzheimers Res Ther. 2013 Apr 29;5(2):21. PMID: 23634965

Clinical symptoms, risk factors and cardiovascular medication in cerebral microangiopathy patients
Okroglic S, Widmann CN, Urbach H, Scheltens P, Heneka MT.
PLOS One, 2013;8(2):e57307. PMID: 23468966

NLRP3 is activated in Alzheimer´s disease and contributes to pathology in APP/PS1 mice
Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Saecker A, Griep A, Axt D, Remus A, Tzeng T, Gelpi E, Halle A, Korte M, Latz E, and Golenbock D
Nature, 2012, doi:10.1038/nature11729